Ticker Symbol: SRNEQ

Sorrento Therapeutics Inc

Exchange: OTC MARKETS Country: US Currency: USD Asset Type: Common Stock CIK:0000850261

Company Profile

sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Standard Industrial Classification Code (SIC code): 8731

Address: 4955 Directors Pl

Website: https://sorrentotherapeutics.com/

CEO: Henry Ji

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $0.08 - $0.09

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 551281154

Valuation

Market Cap: -

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A